#Coronavirus Disease Research #References (AMEDEO, August 1 '26)

 

Antiviral Res

1. WANG K, Gibbons JS, Bisht N, Reyes AC, et al
   SARS-CoV-2 resistance pathways to EDP-235.
   Antiviral Res. 2026;253:106493.
   PubMed         Abstract available
   
   

   
   Emerg Infect Dis

2. KIM S, Chun BC
   Kudoa septempunctata Parasite-Associated Foodborne Disease Outbreaks, South Korea, 2015-2024.
   Emerg Infect Dis. 2026;32:1373-1375.
   PubMed         Abstract available
   
   
3. XU Y, Xiong W, Huang X, Cowling BJ, et al
   Respiratory Syncytial Virus Suppression through Public Health and Social Measures, Hong Kong, China, 2020-2023.
   Emerg Infect Dis. 2026;32:1315-1318.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

4. SPILIOPOULOU A, Betaania L, Giannopoulou I, Leonidou L, et al
   Candidemia in Post-COVID Era: Increasing incidence of endemic fluconazole-resistant Candida parapsilosis and Candidozyma auris.
   Int J Infect Dis. 2026 Jul 30:109018. doi: 10.1016/j.ijid.2026.109018.
   PubMed         Abstract available
   
   
5. GARNERET P, Gaubert G, Nauleau S, Franke F, et al
   Social Deprivation and Remoteness as Determinant of COVID-19 Hospitalisations and Severity: an Area-Level Analysis in South-Eastern France.
   Int J Infect Dis. 2026 Jul 30:109013. doi: 10.1016/j.ijid.2026.109013.
   PubMed         Abstract available
   
   
6. GRIMM K, Hodel EM, Gasser L, Schuller S, et al
   Feasibility of studying respiratory infection transmission in a Swiss household cohort: Findings from the BEready ("Bern, get ready") study.
   Int J Infect Dis. 2026 Jul 29:109019. doi: 10.1016/j.ijid.2026.109019.
   PubMed         Abstract available
   
   
7. RAHAJAMANANA VL, Rabezanahary H, Arroyave A, Wantchecon A, et al
   Dynamics of neutralizing antibodies against enterovirus D68 in adults during the COVID-19 pandemic.
   Int J Infect Dis. 2026 Jul 27:109008. doi: 10.1016/j.ijid.2026.109008.
   PubMed         Abstract available
   
   

   
   J Med Virol

8. MORETTO SL, Cassela PLCS, Trigo GL, Lozovoy MAB, et al
   Investigation of PDCD1 Gene Polymorphisms and Haplotypes in COVID-19 Severity and Outcome in a Brazilian Population.
   J Med Virol. 2026;98:e71090.
   PubMed         Abstract available
   
   
9. PASITTUNGKUL S, Vichaiwattana P, Poovorawan Y, Wanlapakorn N, et al
   Post-Pandemic Resurgence of Respiratory Syncytial Virus in Thailand: Molecular Epidemiology and Sublineage Turnover Among Children, 2023-2025.
   J Med Virol. 2026;98:e71089.
   PubMed         Abstract available
   
   
10. FRASCA F, Maddaloni L, D'Auria A, Fracella M, et al
    SARS-CoV-2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV.
    J Med Virol. 2026;98:e71067.
    PubMed         Abstract available
    
    
11. HUANG Y, Gao Y, Li Y, Song G, et al
    Application of a Super-Multiplex Microfluidic qPCR System for Detection of Respiratory Pathogens in Patients With Influenza-Like Illness.
    J Med Virol. 2026;98:e71072.
    PubMed         Abstract available
    
    

    
    J Virol

12. XU J, Chan H-w, Yang R, Wu X-R, et al
    Nicotine and cotinine enhance SARS-CoV-2 entry through distinct but complementary mechanisms in human respiratory epithelial cells.
    J Virol. 2026 Jul 31:e0097126. doi: 10.1128/jvi.00971.
    PubMed         Abstract available
    
    
13. LIANG X, Chi X, Deng X
    Coronavirus Nsp15 endoribonuclease: linking viral RNA regulation to immune evasion and viral fitness.
    J Virol. 2026 Jul 31:e0170025. doi: 10.1128/jvi.01700.
    PubMed         Abstract available
    
    
14. ZENG W, Zhang G, Ma H, Xiong L, et al
    ACE2-fused nanobody targeting a cryptic RBD epitope broadly neutralizes SARS-like viruses.
    J Virol. 2026 Jul 30:e0060826. doi: 10.1128/jvi.00608.
    PubMed         Abstract available
    
    
15. HE L, Su Y-WN, Zhang F, Moustafa IM, et al
    Recovery of proofreading-impaired SARS-CoV-2 reveals a mutator phenotype and an ExoN activity threshold for viability.
    J Virol. 2026 Jul 29:e0080926. doi: 10.1128/jvi.00809.
    PubMed         Abstract available
    
    
16. DWIVEDI S, Kar S, Horton AP, Gollihar JD, et al
    ViralMap: predicting features in viral proteins from primary sequence.
    J Virol. 2026 Jul 28:e0075726. doi: 10.1128/jvi.00757.
    PubMed         Abstract available
    
    

    
    Nature

17. CHEN E
    Can long COVID be prevented? Two drugs finally show promise.
    Nature. 2026 Jul 29. doi: 10.1038/d41586-026-02341.
    PubMed        

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, August 1 '26)

 

Arch Virol

1. LEE K, An SH, Heo GB, Lee YJ, et al
   Genomic characterization of H6N1 avian influenza viruses from wild birds and domestic ducks in the republic of Korea and Mongolia (2022-2024).
   Arch Virol. 2026;171:238.
   PubMed         Abstract available
   
   

   
   Biochem Soc Trans

2. MADDUMAGE JC, Dow GR, Murdolo LD, Liwei Leong S, et al
   Deciphering influenza B virus-derived peptides and their presentation by HLA class I molecules.
   Biochem Soc Trans. 2026;54:1021-1052.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

3. IBRAHIM HM, Mansour MGE, Zaitoun R, Rushdy M, et al
   HLA-B class I allele associations with neurological complications in pediatric SARS-CoV-2 infection: a retrospective observational study.
   BMC Pediatr. 2026;26:691.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

4. NAQVI OH, Wendelboe AM, Beasley WH, Tyungu DL, et al
   Epidemiological characteristics of paediatric COVID-19 and influenza co-infections in the United States, 2020-2024.
   Epidemiol Infect. 2026;154:e105.
   PubMed         Abstract available
   
   

   
   J Immunol

5. CHEUNG MW, Choi JD, Stempak JM, Chandran V, et al
   T cell immunity to SARS-CoV-2 vaccination in inflammatory bowel disease patients treated with anti-cytokine biologics.
   J Immunol. 2026;215:vkag173.
   PubMed         Abstract available
   
   
6. NELSON SA, Rattan A, Marathe B, White CL, et al
   Distinct kinetic features of innate and adaptive responses in influenza A versus influenza B-infected mice.
   J Immunol. 2026;215:vkag196.
   PubMed         Abstract available
   
   

   
   J Infect

7. SANZ-MUNOZ I, Ciria-Gil CJ, Hernandez M, Santiago C, et al
   Pre-existing and Cross-Reactive Immunity to Avian Influenza H5N1 in Humans: Implications for Pandemic Risk and Vaccine Strategies.
   J Infect. 2026 Jul 30:106822. doi: 10.1016/j.jinf.2026.106822.
   PubMed         Abstract available
   
   

   
   J Virol

8. MCCAFFREY KD, Esfahani BG, Elbehairy MA, McCormick AL, et al
   Molecular basis for protection and cross-protection by human antibodies targeting the parainfluenza virus hemagglutinin-neuraminidase protein.
   J Virol. 2026 Jul 31:e0050226. doi: 10.1128/jvi.00502.
   PubMed         Abstract available
   
   
9. CHEN X, Yan J, Li M, Liu H, et al
   c-Fos enhances influenza virus replication by stabilizing the M2 protein and promoting autophagosome accumulation.
   J Virol. 2026 Jul 27:e0091626. doi: 10.1128/jvi.00916.
   PubMed         Abstract available
   
   

   
   JAMA

10. BAUDIN F, Pouyau R, Subtil F, Jarrasse C, et al
    Prone Positioning in Infants With Acute Bronchiolitis: The PROPOSITIS Randomized Clinical Trial.
    JAMA. 2026;336:315-322.
    PubMed         Abstract available
    
    

    
    Pediatrics

11. YI Y, Edwards F, Wakefield S, Wildeman C, et al
    Child Welfare System Involvement in the United States: 2016-2023.
    Pediatrics. 2026;158:e2025074635.
    PubMed         Abstract available
    
    
12. MORENO-PEREZ D, Catalan-Fernandez E, Croche-Santander B, Rios-Hurtado JM, et al
    Nirsevimab and Hospitalization for Lower Respiratory Tract Infection During the Second Season.
    Pediatrics. 2026;158:e2025075562.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

13. XU R, Ghaffarzadegan N, Zhang G, Aoki G, et al
    Population-level behavioral and structural drivers of COVID-19 vaccine uptake in the US.
    PLoS Comput Biol. 2026;22:e1013988.
    PubMed         Abstract available
    
    
14. BEAULIEU M, Hoze N, Vieillefond V, Goetschy T, et al
    Quantitative analysis of massive SARS-CoV-2 testing in the community in France in 2021-2022 reveals the associations of variant, vaccination, and age with viral dynamics in symptomatic individuals.
    PLoS Comput Biol. 2026;22:e1013811.
    PubMed         Abstract available
    
    

    
    PLoS One

15. ZHU K, Barberio J, Tsao N, Mor A, et al
    Trends in the incidence of asthma, atopic dermatitis, and multiple sclerosis before, during, and after the COVID-19 pandemic in a US claims database.
    PLoS One. 2026;21:e0355103.
    PubMed         Abstract available
    
    
16. BRANNON GE, Chatterjee K, Jang CY, Markham Shaw C, et al
    Perceptions of Spanish-language COVID-19 video messaging among the Hispanic community: A qualitative study in the United States of America.
    PLoS One. 2026;21:e0339634.
    PubMed         Abstract available
    
    
17. NELSON AK, Everett M, Smith R, Rogers L, et al
    Death by incarceration: Detention duration, overdose, and COVID-19 in Los Angeles County Jails, 2008-2023.
    PLoS One. 2026;21:e0351332.
    PubMed         Abstract available
    
    
18. CASTRO MONTEIRO F, Luiza C Wuillaume M, Linhares Veloso Filho C, Figueiredo K, et al
    Identifying cluster profiles based on barriers and facilitators to physical activity during COVID-19 confinement: A cross-sectional study using machine learning analysis.
    PLoS One. 2026;21:e0354036.
    PubMed         Abstract available
    
    
19. SUN L, Jiang Z, Chen Y, Han M, et al
    Exploring the mechanism of Shuangyu Granule in regulating immune-inflammatory responses in influenza through UPLC-Orbitrap-MS/MS, GC-MS, and network target analysis.
    PLoS One. 2026;21:e0353259.
    PubMed         Abstract available
    
    
20. ROY SS, Nguyen NT, Zuniga A, Sarhaddi F, et al
    Mission imputable: Effects of missing data processing on infectious disease detection and prognosis.
    PLoS One. 2026;21:e0320105.
    PubMed         Abstract available
    
    
21. ABUSKA D, Dikme O, Dikme O, Yurttas TT, et al
    Age-stratified prognostic performance of hematologic inflammatory indices for 30-day mortality in emergency department patients with PCR-confirmed COVID-19: A cohort study from the pre-vaccination pandemic era.
    PLoS One. 2026;21:e0354809.
    PubMed         Abstract available
    
    
22. CALLAGHAN CW
    Cultural tightness and scientific capacity: A cross-national study of their synergistic and conflicting roles in COVID-19 pandemic outcomes.
    PLoS One. 2026;21:e0330983.
    PubMed         Abstract available
    
    
23. KEBEDE M, Kusheta G, Jemal M, Abdurehman K, et al
    Determinants of parental traditional medicine use for children during COVID-19 in Dire Dawa city administration, Eastern Ethiopia, 2023/24: Mixed community based cross-sectional study design.
    PLoS One. 2026;21:e0354889.
    PubMed         Abstract available
    
    
24. LIM MS, Park C, Lee E, Ko SY, et al
    A multiplex dual-probe RT-LAMP assay for rapid subtype-specific detection of respiratory syncytial virus A and B.
    PLoS One. 2026;21:e0354914.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

25. HAN AX, Hulme KD, Russell CA
    The global demand and potential public health impact of oral antiviral treatment stockpile for influenza pandemics.
    Proc Natl Acad Sci U S A. 2026;123:e2524161123.
    PubMed         Abstract available
    
    
26. GERVAIS A, Marchal A, Maillard A, Le Voyer T, et al
    High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.
    Proc Natl Acad Sci U S A. 2026;123:e2518581123.
    PubMed         Abstract available
    
    

    
    Vaccine

27. LIU B, Li F, Yang Y, Tu H, et al
    In-depth monitoring of host cell proteins in influenza vaccines throughout multi-step purification processes.
    Vaccine. 2026;88:128957.
    PubMed         Abstract available
    
    
28. KOSTANYAN L, Fukase H, Rumyantsev A, Hashizume K, et al
    Immunogenicity, reactogenicity, and safety of an mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine, mRNA-1083, in adults aged >/=50 years in Japan.
    Vaccine. 2026;88:128961.
    PubMed         Abstract available
    
    
29. WEI Z, Feng X, Sun Q, Chen D, et al
    Factors affecting parental practices and attitudes toward influenza vaccination for children in China.
    Vaccine. 2026;88:128988.
    PubMed         Abstract available

#Coronavirus Disease Research #References (AMEDEO, July 25 '26)

 

BMJ

1. 
   Addressing the indirect health burden of covid-19.
   BMJ. 2026;394:e100376.
   PubMed        
   
   
2. 
   Reduced disease detection during covid-19.
   BMJ. 2026;394:e100377.
   PubMed        
   
   

   
   Clin Infect Dis

3. ISKANDER JK, Haridopolos S
   Making Invisible Illnesses Visible: Recognizing and Responding to Infection-Associated Chronic Conditions.
   Clin Infect Dis. 2026;83:e58-e61.
   PubMed         Abstract available
   
   

   
   Infect Control Hosp Epidemiol

4. MCGILL E, Lee D, Quach C, Leis JA, et al
   Hospital characteristics associated with healthcare-associated viral respiratory infection rates in a Canadian acute care network.
   Infect Control Hosp Epidemiol. 2026 Jul 22:1-9. doi: 10.1017/ice.2026.10490.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

5. JO S, Min KD, Cho SI
   Counterfactual Evaluation of COVID-19 Control Policies in South Korea: A Scenario-Based Modeling Study.
   Int J Infect Dis. 2026 Jul 22:108997. doi: 10.1016/j.ijid.2026.108997.
   PubMed         Abstract available
   
   

   
   Intensive Care Med

6. EHRMANN S, Li J, Liu L, Guerin C, et al
   Prone positioning in ARDS.
   Intensive Care Med. 2026 Jul 20. doi: 10.1007/s00134-026-08543.
   PubMed         Abstract available
   
   

   
   J Infect

7. QUINOT C, Lunt R, Kirsebom F, Andrews N, et al
   Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England.
   J Infect. 2026;93:106819.
   PubMed         Abstract available
   
   

   
   J Med Virol

8. ZUNIGA-HERNANDEZ ME, Reyes-Barrera KL, Hidalgo-Figueroa SN, Paez-Perez ED, et al
   ACE2- and HR2-Mimetic Peptides Inhibit Replication of Two SARS-CoV-2 Variants.
   J Med Virol. 2026;98:e71060.
   PubMed         Abstract available
   
   
9. RIZZO A, Salari F, Galli C, Maffeo M, et al
   Integrated Hospital, Emergency Department, and Community Surveillance for Respiratory Viruses in Milan, Italy.
   J Med Virol. 2026;98:e71073.
   PubMed         Abstract available
   
   
10. JAVED A, Hayat J, Haider SA, Jamal Z, et al
    Molecular Surveillance and Genomic Characterization of Influenza A(H3N2) Viruses From a Secondary-Care Surveillance Site in Pakistan During the 2025-2026 Winter Season.
    J Med Virol. 2026;98:e71075.
    PubMed         Abstract available
    
    

    
    J Virol

11. HERNANDEZ PC, Moeller NH, Aihara H
    Distinct modes of RNA degradation by the structurally related coronavirus and arenavirus exoribonucleases.
    J Virol. 2026 Jul 23:e0079826. doi: 10.1128/jvi.00798.
    PubMed         Abstract available
    
    
12. LIU X, Wang L, Liu Y, Xiong M, et al
    Single-cell RNA sequencing identifies uterine stromal cells as a previously unrecognized target of an alphacoronavirus underlying reproductive disorders.
    J Virol. 2026 Jul 22:e0023726. doi: 10.1128/jvi.00237.
    PubMed         Abstract available
    
    
13. XU Y, Mou C, Xiang Y, Liu H, et al
    HERPUD1 suppresses porcine epidemic diarrhea virus replication by recruiting HRD1 to degrade viral ORF3 protein.
    J Virol. 2026;100:e0062626.
    PubMed         Abstract available
    
    
14. BEETON K, Case JB
    Respiratory mucosal vaccines for emerging viruses: promise and challenges.
    J Virol. 2026 Jul 23:e0174825. doi: 10.1128/jvi.01748.
    PubMed         Abstract available
    
    
15. FANG P, Xiao W, Wang X, Xiong Y, et al
    Identification of TMEM41B TM6 as a critical domain for coronavirus replication in vitro and in vivo.
    J Virol. 2026 Jul 24:e0049326. doi: 10.1128/jvi.00493.
    PubMed         Abstract available
    
    

    
    JAMA

16. CAMILLERI M
    Gastroparesis: A Review.
    JAMA. 2026 Jul 22. doi: 10.1001/jama.2026.12181.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

17. HOFFMANN M, Shandheep A, Pavlou A, Rahmel-Stein K, et al
    Pseudovirus-based analysis of host cell entry and vaccine-induced neutralisation of Bundibugyo virus.
    Lancet Infect Dis. 2026 Jul 23:S1473-3099(26)00407.
    PubMed        
    
    
18. WU M, Hong H, Guo Y, Daniel K, et al
    SARS-CoV-2 BA.3.2.2 is more evasive of neutralisation by plasma from young children.
    Lancet Infect Dis. 2026 Jul 22:S1473-3099(26)00349.
    PubMed        
    
    
19. ONYEAGHALA C
    A defining clinical moment during the COVID-19 pandemic in Nigeria.
    Lancet Infect Dis. 2026;26:e277.
    PubMed        
    
    
20. AHMAD N, Ure R, MacDonald L, Keegan S, et al
    Genomic epidemiology of invasive meningococcal disease in Scotland before, during, and after the COVID-19 pandemic: a retrospective observational study.
    Lancet Infect Dis. 2026 Jul 21:S1473-3099(26)00284.
    PubMed         Abstract available
    
    

    
    Nature

21. 
    Mapping drivers of life expectancy change in Asia from 1990 to 2023.
    Nature. 2026 Jul 22. doi: 10.1038/s41586-026-10739.
    PubMed         Abstract available
    

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, July 25 '26)

 

Ann Intern Med

1. JOHNSON D, Quinn S, Algase LF, Watkins C Jr, et al
   Telemedicine Policy and Practice: A Position Paper From the American College of Physicians.
   Ann Intern Med. 2026 May 12. doi: 10.7326/ANNALS-25-04194.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

2. KHALILIAN MR, Goudarzi A, Karimi A, Fahimzad A, et al
   Echocardiographic assessment of cardiac involvement in pediatric COVID-19 patients: a cross-sectional study.
   BMC Pediatr. 2026;26:677.
   PubMed         Abstract available
   
   

   
   J Clin Microbiol

3. LUUKINEN B, Lang M, Peltola M, Soinila A, et al
   From triplex to tetraplex: evaluation of the diagnostic accuracy of the new Roche Cobas Liat SARS-CoV-2, influenza A/B & RSV assay.
   J Clin Microbiol. 2026 Jul 20:e0027426. doi: 10.1128/jcm.00274.
   PubMed         Abstract available
   
   

   
   J Infect Dis

4. ZHOU W
   Repeated Influenza Vaccination in Children: Effect Scale, Timing, and Causal Interpretation.
   J Infect Dis. 2026 Jul 24:jiag386. doi: 10.1093.
   PubMed        
   
   

   
   J Virol

5. FAN M, Liu Z, Deng L, Zheng Y, et al
   LncRNA ckATP1A1-AS1 inhibits influenza A virus replication by mediating innate immune responses and suppressing viral nuclear import.
   J Virol. 2026 Jul 24:e0025926. doi: 10.1128/jvi.00259.
   PubMed         Abstract available
   
   
6. ADENUGBA AR, Bohn P, Yu J, Fehrholz M, et al
   Sequence heterogeneity in pneumonia virus of mice reveals G gene-dependent modulation of virulence.
   J Virol. 2026;100:e0010326.
   PubMed         Abstract available
   
   
7. MURRAY A, Nagaraj D, Schultz EM, Aloisio G, et al
   RSV can infect the human nasal epithelium via the basolateral route and shows distinct subgroup infectivity and basal cell tropism.
   J Virol. 2026;100:e0037426.
   PubMed         Abstract available
   
   
8. AO Z, Vendramelli R, Buyu M, Truong T, et al
   A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin and matrix protein 2 induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse model.
   J Virol. 2026 Jun 16:e0009726. doi: 10.1128/jvi.00097.
   PubMed         Abstract available
   
   
9. ZHANG Q, Xin J, Wang C, Zhang X, et al
   Cleavage of TOM1 by the SARS-CoV-2 main protease NSP5 prevents autophagic degradation of viral envelope.
   J Virol. 2026 Jun 12:e0043426. doi: 10.1128/jvi.00434.
   PubMed         Abstract available
   
   
10. GIL-REDONDO JC, Riomoros-Barahona V, Valiente L, Valbuena A, et al
    Different mechanisms for human rhinovirus survival in the presence of deleterious amino acid substitutions at virion protein-protein or RNA-protein interfaces.
    J Virol. 2026;100:e0051126.
    PubMed         Abstract available
    
    
11. WILT I, Jolley AA, Rahman K, Lai KK, et al
    IFITM1 and IFITM3 cooperate to restrict virus entry in endolysosomes.
    J Virol. 2026;100:e0067726.
    PubMed         Abstract available
    
    
12. VARGAS DA, Albornoz LL, Pena-Morales M, Ortiz Rojas HJ, et al
    Within-host SARS-CoV-2 diversity in immunocompromised patients during acute infection.
    J Virol. 2026 Jun 9:e0222425. doi: 10.1128/jvi.02224.
    PubMed         Abstract available
    
    
13. YU H-M, Zhu M-L, Zhao Y-L, Tan J-X, et al
    Research progress on the association between viruses and cardiac diseases.
    J Virol. 2026 Jun 9:e0038326. doi: 10.1128/jvi.00383.
    PubMed         Abstract available
    
    

    
    J Virol Methods

14. HSIEH YH, Su CC, Lee CC, Chen PL, et al
    Analytical characteristics of the NeuMoDx SARS-CoV-2 assay and clinical agreement with the BD MAX system.
    J Virol Methods. 2026;345:115431.
    PubMed         Abstract available
    
    
15. WANG B, Wang J, Sun Z, Sun G, et al
    Epidemiological characteristics of respiratory syncytial virus in children during 2021-2024.
    J Virol Methods. 2026;345:115433.
    PubMed         Abstract available
    
    

    
    Pediatrics

16. KAO CM, Bahakel H, Heald-Sargent TA, Minniear TD, et al
    Influenza, COVID-19, and RSV Vaccinations for Immunocompromised Children and Household Contacts.
    Pediatrics. 2026 Jul 23:e2026075971. doi: 10.1542/peds.2026-075971.
    PubMed         Abstract available
    
    

    
    PLoS Genet

17. WEYKOPF G, Bickmore WA, Biddie SC, Friman ET, et al
    Identifying severe COVID-19 risk variants modulating enhancer reporter activity in lung cells.
    PLoS Genet. 2026;22:e1012222.
    PubMed         Abstract available
    
    

    
    PLoS Med

18. LI W, Yang W, Liu Y, Yao Y, et al
    Assessing spatial transmission risk of respiratory infectious diseases across cities of different socioeconomic tiers in China: A modelling study.
    PLoS Med. 2026;23:e1005172.
    PubMed         Abstract available
    
    
19. GRAIS RF
    Whose fears count? Legitimacy, trust and viral outbreak responses after COVID-19.
    PLoS Med. 2026;23:e1005184.
    PubMed         Abstract available
    
    

    
    PLoS One

20. CHURCHILL BF, Gao XS, Rong R
    Partisan differences in healthcare decision-making: Evidence from a vaccine experiment.
    PLoS One. 2026;21:e0352319.
    PubMed         Abstract available
    
    
21. SCHEPISI C, Ventura M, Di Napoli A, Aragona M, et al
    The effect of COVID-19 and socioeconomic inequalities on emergency department accesses for psychiatric conditions.
    PLoS One. 2026;21:e0324305.
    PubMed         Abstract available
    
    
22. SUZUKI T, Kita Y, Yanagida K, Maeda K, et al
    Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey.
    PLoS One. 2026;21:e0352423.
    PubMed         Abstract available
    
    
23. ELLIS K, Hall P, Robinson L, Ruiz S, et al
    COVID-19 vaccine confidence among adults of pima county using the NIMHD minority health and health disparities research framework: A qualitative analysis.
    PLoS One. 2026;21:e0353345.
    PubMed         Abstract available
    
    
24. HIRSCH JA, Besser LM, Pescador Jimenez M, Dickinson ST, et al
    Spatial and neighborhood data in the collaborative cohort of cohorts for COVID-19 Research (C4R).
    PLoS One. 2026;21:e0352170.
    PubMed         Abstract available
    
    
25. LA EM, Gallington K, Singer D, Fikre T, et al
    US healthcare professionals' knowledge, attitudes, and practices regarding RSV disease and vaccination in adults during the 2024-2025 RSV season.
    PLoS One. 2026;21:e0353266.
    PubMed         Abstract available
    
    
26. HAMUNAKWADI DL, Smith SL
    The news media and the agenda for noncommunicable diseases before and during the COVID-19 pandemic: Losing the competition for coverage and framing responsibility for action in Malawi.
    PLoS One. 2026;21:e0341285.
    PubMed         Abstract available
    
    
27. IBRAHIM S, Yakubu Y, Appiagyei K, Sylvester AFD, et al
    Factors associated with severe acute respiratory syndrome coronavirus-2 infection in Hohoe Municipality, Ghana: A case-control study.
    PLoS One. 2026;21:e0332561.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

28. MISTRY HB
    Hazard curvature makes within-host variability costly for survival.
    Proc Natl Acad Sci U S A. 2026;123:e2610568123.
    PubMed         Abstract available
    
    

    
    Vaccine

29. OKOLI GN, Sullivan SG, Harper DM, Tsang TK, et al
    A systematic meta-analytic comparative evaluation of seasonal influenza vaccine effectiveness from test-negative design studies in the Northern Hemisphere pre/post COVID-19 pandemic.
    Vaccine. 2026;88:128956.
    PubMed         Abstract available
    
    
30. WANG WC, Alhashimi M, Gairola V, Murala MST, et al
    Lung-resident T-cell immunity dominates protection induced by an intranasal adenoviral nucleoprotein influenza vaccine.
    Vaccine. 2026;88:128962.
    PubMed         Abstract available
    
    

    
    Virology

31. YOSHIDA K, Yamamoto S, Ogasawara N, Taniguchi K, et al
    Innate immune-regulated sulfated glycosaminoglycans are associated with progeny respiratory syncytial virus retention at the cell surface in immortalized cell lines.
    Virology. 2026;623:110974.
    PubMed         Abstract available
    
    
32. DICKERSON A, Cruceanu A, Pokharel BR, Majumdar N, et al
    Deciphering the miR-29c-3p / TET3 regulatory axis within the SARS-CoV-2-infected midbrain.
    Virology. 2026;623:110989.
    PubMed         Abstract available
    
    
33. WANG Z, Pan Q, Arduini A, Liang C, et al
    Identification of SARS-CoV-2 proteins suppressing host protein synthesis.
    Virology. 2026;623:111006.
    PubMed         Abstract available
    
    
34. MANDVIWALA AS, Liman K, Huckriede ALW, Mishra AC, et al
    Evaluation of MPLA and chimeric TLR agonist adjuvants in RSV virus-like particle vaccines delivered by the intramuscular route.
    Virology. 2026;623:111007.
    PubMed         Abstract available
    
    
35. ABDEL-MONEIM AS, Al-Balushi MS, Al-Jabri AA
    Post-COVID-19 immune dysregulation and autoimmune sequelae.
    Virology. 2026;623:111017.
    PubMed         Abstract available
    
    

    
    Virus Res

36. TANG Y, Gao X, Ding H, Kong L, et al
    Biological Aging, Immune Phenotypes, and Susceptibility to COVID-19 and Sepsis: A Mendelian Randomization Study.
    Virus Res. 2026;370:199756.
    PubMed         Abstract available

#Coronavirus Disease Research #References (AMEDEO, July 19 '26)

 

Clin Infect Dis

1. PAYNE DC, Weinberg GA, Halasa NB, Englund JA, et al
   The New Vaccine Surveillance Network: 25 years of active, population-based surveillance for pediatric infectious diseases in the United States.
   Clin Infect Dis. 2026 Jul 13:ciag434. doi: 10.1093.
   PubMed         Abstract available
   
   
2. MEYEROWITZ EA, Richterman A
   Hantavirus on a Cruise Ship: What COVID-19 Taught Us.
   Clin Infect Dis. 2026 Jul 11:ciag428. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Emerg Infect Dis

3. FALENDER R, Kaya D, Harry M, Hachimi O, et al
   Targeted Wastewater Surveillance during the World Athletics Championship, Oregon, USA, 2022.
   Emerg Infect Dis. 2026;32.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

4. AUBRY A, Brochot E, Demey B, Louchet-Ducoroy M, et al
   Epidemiological trends in viral CNS infections in a French university hospital from 2019 to 2024, as revealed by multiplex PCR testing of cerebrospinal fluid samples.
   Int J Infect Dis. 2026 Jul 12:108977. doi: 10.1016/j.ijid.2026.108977.
   PubMed         Abstract available
   
   

   
   J Infect

5. HANSEN CL, Shaikh N, Naeger S, Torcel-Pagnon L, et al
   Hospitalizations and deaths from major respiratory viruses in the US: An ensemble time series modeling study, 2016-2025.
   J Infect. 2026;93:106811.
   PubMed         Abstract available
   
   

   
   J Med Virol

6. RIZZUTO J, Amarin JZ, Polic A, Howe HL, et al
   Severe COVID-19 in Pregnant Versus Nonpregnant Women: Intensive Care Unit Outcomes and Perinatal Risks.
   J Med Virol. 2026;98:e71036.
   PubMed         Abstract available
   
   

   
   J Virol

7. LOU J, Guo Z, Chen K, Tian Y, et al
   Cyclo-C stabilizes PEX13 to inhibit porcine epidemic diarrhea virus replication by blocking pexophagy-mediated disruption of antiviral innate immunity.
   J Virol. 2026 Jul 17:e0078526. doi: 10.1128/jvi.00785.
   PubMed         Abstract available
   
   
8. OVERSTI S, Lytras S, Kawakubo S, Ito J, et al
   From sites to structure to serology: a roadmap for structure-aware molecular evolution of antigenically evolving viruses.
   J Virol. 2026 Jul 16:e0168725. doi: 10.1128/jvi.01687.
   PubMed         Abstract available
   
   
9. KAWAHARA S, Nao N, Tulakarnwong S, Suzuki S, et al
   GC content mismatch of transgene destabilizes RNA virus genomes.
   J Virol. 2026 Jul 13:e0088226. doi: 10.1128/jvi.00882.
   PubMed         Abstract available
   
   

   
   Lancet

10. CRIVELLI L, Suemoto CK, Sosa AL, Lopera F, et al
    Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.
    Lancet. 2026 Jul 13:S0140-6736(26)01278-X. doi: 10.1016/S0140-6736(26)01278.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

11. OPPEGAARD O, Blomberg B, Cox RJ, Iversen A, et al
    Nirmatrelvir for acute COVID-19 to prevent long COVID (PANORAMIC Norway): a double-blind, randomised, placebo-controlled trial.
    Lancet Infect Dis. 2026 Jul 16:S1473-3099(26)00244.
    PubMed         Abstract available
    
    
12. NAIDOO T, Morgenstern C, Doohan P, Earl R, et al
    A systematic review of Nipah virus disease epidemiological parameters, outbreaks, and mathematical models.
    Lancet Infect Dis. 2026 Jul 14:S1473-3099(26)00239.
    PubMed         Abstract available
    
    

    
    N Engl J Med

13. WARKENTIN TE, Greinacher A
    Platelet-Activating Anti-Platelet Factor 4 Disorders.
    N Engl J Med. 2026 Jul 13. doi: 10.1056/NEJMra2502459.
    PubMed         Abstract available
    
    

    
    Nature

14. 
    Party pooper: grandparents' COVID risk rose after grandchildren's birthdays.
    Nature. 2026 Jul 13. doi: 10.1038/d41586-026-02194.
    PubMed        
    
    
15. GULLAND A
    This microbiologist endured a four-year court battle over COVID-19 tests.
    Nature. 2026 Jul 13. doi: 10.1038/d41586-026-01654.
    PubMed        
    

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, July 19 '26)

 

BMC Pediatr

1. CHOO MY, Lum LCS, Jalal MIA, Ooi KS, et al
   Nutritional disparities between urban poor and non-poor Malaysian children under five in the context of the COVID-19 pandemic: a cross-sectional study.
   BMC Pediatr. 2026 Jun 5. doi: 10.1186/s12887-026-07079.
   PubMed         Abstract available
   
   
2. KENDRIC KJ, Durrani TS
   Trends in pediatric household cleaning product exposures before and during the COVID-19 pandemic: a national poison data system analysis (2016-2023).
   BMC Pediatr. 2026;26:658.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

3. AMEMIYA Y, Nishiura H
   Using forensic autopsy data to estimate the age-specific infection fatality risk of COVID-19.
   Epidemiol Infect. 2026;154:e96.
   PubMed         Abstract available
   
   
4. MCGEOCH L, Stoker K, Rome M, Carey C, et al
   What is the burden of respiratory syncytial virus outbreaks in care homes? An enhanced surveillance study in England, winter 2024/25.
   Epidemiol Infect. 2026;154:e99.
   PubMed         Abstract available
   
   

   
   J Epidemiol Community Health

5. WING K, Morton C, Mahalingasivam V, Costello RE, et al
   Occurrence and persistence of symptoms, diagnoses and prescriptions after community-diagnosed COVID-19: a matched cohort study using the OpenSAFELY platform.
   J Epidemiol Community Health. 2026;80:624-634.
   PubMed         Abstract available
   
   

   
   J Infect Dis

6. FLANNERY B, Chung JR, Holiday C, Jefferson S, et al
   Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018-May 2019.
   J Infect Dis. 2026 Jul 17:jiag371. doi: 10.1093.
   PubMed         Abstract available
   
   
7. KAWAI N, Bando T, Kawashima T, Matsuura S, et al
   Influenza Attack Rates and Vaccine Effectiveness by Prior-Season Infection and Vaccination: A 17-Season Analysis.
   J Infect Dis. 2026 Jul 11:jiag352. doi: 10.1093.
   PubMed         Abstract available
   
   
8. ROGERS S, Sumner KM, Yang Y, Johnson E, et al
   Protective effects of influenza B neuraminidase antibodies against symptomatic influenza virus infection.
   J Infect Dis. 2026 Jul 10:jiag351. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

9. CIMINSKI K, Reuther P, Rijkers R, de Vries RP, et al
   The receptor landscape of influenza A viruses.
   J Virol. 2026 Jul 16:e0144325. doi: 10.1128/jvi.01443.
   PubMed         Abstract available
   
   
10. SHIRAZI R, Kim SY, Cruz A, Stumpff JP, et al
    RELMalpha establishes a permissive environment for influenza virus infection through direct effects on lung epithelial cells.
    J Virol. 2026 Jul 16:e0222525. doi: 10.1128/jvi.02225.
    PubMed         Abstract available
    
    

    
    Lancet

11. BLAKNEY AK, Top KA, Cowling BJ, Larson HJ, et al
    Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.
    Lancet. 2026 Jun 30:S0140-6736(26)00512-X. doi: 10.1016/S0140-6736(26)00512.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

12. DA SILVA K, Naffakh N, Rameix-Welti MA, Lemoine F, et al
    Accounting for Defective Viral Genomes in viral consensus genome reconstruction, application to influenza virus.
    PLoS Comput Biol. 2026;22:e1014115.
    PubMed         Abstract available
    
    

    
    PLoS One

13. OKUI T
    Difference in excess mortality during the COVID-19 pandemic depending on marital status in Japan.
    PLoS One. 2026;21:e0354263.
    PubMed         Abstract available
    
    
14. KARIM A, Al Mamun MA, Sultana S, Kabilan MK, et al
    Teaching persuasive essay writing online to first-year undergraduates: A phenomenological study of instructional design and learning experiences.
    PLoS One. 2026;21:e0353171.
    PubMed         Abstract available
    
    
15. MICHEL S, Kempf C, Pirschtat N, Herbstreit F, et al
    Herpesvirus reactivation is associated with mortality in critically ill ICU patients with COVID-19: Insights from a retrospective single-center analysis of 455 cases.
    PLoS One. 2026;21:e0354153.
    PubMed         Abstract available
    
    
16. MA C, Sun J, Liu Z, Zhang C, et al
    Skin manifestations of primary COVID-19 infection with the omicron variant.
    PLoS One. 2026;21:e0352201.
    PubMed         Abstract available
    
    
17. MADDEN D
    Covid-19 related excess mortality: An analysis by age for selected countries.
    PLoS One. 2026;21:e0353766.
    PubMed         Abstract available
    
    
18. BOMANS S, Michotte N, El M'Rabet I, Jimenez Garcia B, et al
    Agreement and reliability between the two-day 6-minute incremental step test and two-day cardiopulmonary exercise test in post COVID-19 condition for assessing post-exertional malaise: The REVEAL-study.
    PLoS One. 2026;21:e0353132.
    PubMed         Abstract available
    
    
19. CAPODICI A, Filippeschi A, Noci F, Michelucci A, et al
    Mapping global inequities in telemedicine implementation: An umbrella review of barriers and facilitators.
    PLoS One. 2026;21:e0351885.
    PubMed         Abstract available
    
    
20. WIELAND V, Wassmuth N, Contento L, Kuhn M, et al
    Assessment of simulation-based inference methods for stochastic compartmental models in epidemiological research.
    PLoS One. 2026;21:e0353306.
    PubMed         Abstract available
    
    
21. DILILLO KM, Forconi CS, Matta A, Melo J, et al
    Estimating SARS-CoV-2 exposure in asymptomatic hospitalized children with cancer in Western Kenya: A retrospective analysis of serological data.
    PLoS One. 2026;21:e0353284.
    PubMed         Abstract available
    
    
22. ROBINSON B, Bisaillon P, Sandhu R, Khalil M, et al
    Semi-analytical hierarchical Bayesian inference of nonlinear model structure in stochastic dynamics: Applied to compartmental models of infectious diseases.
    PLoS One. 2026;21:e0350747.
    PubMed         Abstract available
    
    
23. ROSYCHUK RJ, Lee BE, Qiu JY, Gao T, et al
    Exploring the predictability of distributed lag nonlinear models using SARS-CoV-2 wastewater-based surveillance in multiple communities in Alberta, Canada.
    PLoS One. 2026;21:e0349030.
    PubMed         Abstract available
    
    
24. KAYUMBA K, Duga A, Papa Fallah M, Tshidibi C, et al
    Adverse events following immunization during COVID-19 mass vaccination campaigns in the Democratic Republic of Congo: Findings from active safety surveillance.
    PLoS One. 2026;21:e0309628.
    PubMed         Abstract available
    
    

    
    Vaccine

25. TU T, Tseng CY, Islam MD, Hsu WL, et al
    Adjuvant-free pH-controlled aggregates of E. coli-expressed H1N1-RBD enhance neutralizing antibody responses and confer protection against influenza virus.
    Vaccine. 2026;88:128898.
    PubMed         Abstract available
    
    
26. GROOTENDORST A, Paludan-Muller AS, Madsen K, Stovring H, et al
    Expanding enhanced influenza vaccines programs for adults aged >/=65 in the Nordic region predicted to improve public health and health system resilience.
    Vaccine. 2026;88:128934.
    PubMed         Abstract available
    

#Coronavirus Disease Research #References (AMEDEO, July 11 '26)

 

Am J Respir Crit Care Med

1. JERRETT M, Nau CL, Young DR, Butler RK, et al
   Association Between Air Pollution and Post Acute Sequelae of SARS-CoV-2 (PASC).
   Am J Respir Crit Care Med. 2026 Jul 3:aamag341. doi: 10.1093.
   PubMed        
   
   

   
   Ann Intern Med

2. DARNALL BD, Perez L, Kao MC, Lorig K, et al
   Patient-Centered Prescription Opioid Tapering Methods : A Randomized Clinical Trial.
   Ann Intern Med. 2026 Jul 7. doi: 10.7326/ANNALS-25-04784.
   PubMed         Abstract available
   
   

   
   BMJ

3. HAQ ZU
   Ebola control is weakened by mistrust and cultural insensitivity.
   BMJ. 2026;394:e100190.
   PubMed        
   
   

   
   Clin Infect Dis

4. ROSTER KIO, White PJ, Grad YH
   Why Are Gonorrhea Case Rates Declining in the United States? A Research Agenda.
   Clin Infect Dis. 2026;82:1082-1090.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

5. MIYAKAWA K, Sano K, Seki Y, Sato R, et al
   Cross-neutralization of SARS-CoV-2 BA.3.2.2 lineage by JN.1 mRNA vaccine-induced immunity.
   Int J Infect Dis. 2026 Jul 4:108954. doi: 10.1016/j.ijid.2026.108954.
   PubMed         Abstract available
   
   
6. JO Y, Hu Z, Joo H, Jung J, et al
   Time to Recovery from Long COVID: A Longitudinal Analysis of Symptom Duration and Risk Factors Using Accelerated Failure Time Models.
   Int J Infect Dis. 2026 Jul 5:108963. doi: 10.1016/j.ijid.2026.108963.
   PubMed         Abstract available
   
   
7. CHUI CSL, Lau JC, Fan M, Chan BP, et al
   Concurrent comparison of severity of influenza and COVID-19 among hospitalized patients in Hong Kong: a target trial emulation on observational healthcare data.
   Int J Infect Dis. 2026 Jul 7:108958. doi: 10.1016/j.ijid.2026.108958.
   PubMed         Abstract available
   
   
8. JABER F, Rawas SE, Faraj S, Zoghby LA, et al
   Value of the Pitt bacteremia score in predicting the outcome of non-bacteremic patients with infections caused by multidrug-resistant organisms.
   Int J Infect Dis. 2026 Jul 7:108960. doi: 10.1016/j.ijid.2026.108960.
   PubMed         Abstract available
   
   
9. ACANFORA D, Nolano M, Acanfora C, Colella C, et al
   Vagal cholinergic denervation of the gastric mucosa in Long-COVID-19: in vivo evidence of structural autonomic dysfunction.
   Int J Infect Dis. 2026 Jul 9:108973. doi: 10.1016/j.ijid.2026.108973.
   PubMed         Abstract available
   
   

   
   J Infect

10. VINK E, Murphy ME, Gunson R, MacConnachie A, et al
    Respiratory viral detection in adult severe acute respiratory infection post-COVID-19 pandemic: implications for antimicrobial stewardship.
    J Infect. 2026;93:106805.
    PubMed         Abstract available
    
    

    
    J Med Virol

11. BUMBERGER AM, Kastner MT, Gawish R, Rusing L, et al
    Torque Teno Virus Dynamics in Plasma and BAL of COVID-19 ARDS Patients With and Without ECMO.
    J Med Virol. 2026;98:e71047.
    PubMed         Abstract available
    
    
12. WENINGER J, Zedginidze A, Katsounas A, Pohl M, et al
    Assessment of Residual-Serum SARS-CoV-2-N-Antigen Testing for Hospital Surveillance in Germany.
    J Med Virol. 2026;98:e71055.
    PubMed         Abstract available
    
    
13. GORIS M, Valdez M, Lamont L, Yang W, et al
    Tracking COVID-19 Severity and Progression Through Amines and Lipid Mediators.
    J Med Virol. 2026;98:e71030.
    PubMed         Abstract available
    
    
14. TUNER B, Agca H
    Molecular Types of Rhinovirus Among Cases of Acute Respiratory Infections in a University Hospital.
    J Med Virol. 2026;98:e71058.
    PubMed         Abstract available
    
    

    
    J Virol

15. LIANG Y-F, Li X, Zhu G-x, Song Y, et al
    Magnolol inhibits porcine epidemic diarrhea virus infection by suppressing cathepsin L expression in vitro and in vivo.
    J Virol. 2026 Jun 25:e0013726. doi: 10.1128/jvi.00137.
    PubMed         Abstract available
    
    
16. ZHAO Y, Zhao J, Li Y, Duan L, et al
    Disruption of the S1/S2 multibasic cleavage site attenuates infectious bronchitis virus, while S2' partially restores viral virulence and expands tissue tropism.
    J Virol. 2026 Jul 6:e0061426. doi: 10.1128/jvi.00614.
    PubMed         Abstract available
    
    
17. STEFANOS B, Green NRB, Nadig I, Lapierre LA, et al
    Coronavirus membrane protein with a fluorescent protein tag enables particle tracking for the study of virus assembly and egress in live cells.
    J Virol. 2026 Jul 6:e0222825. doi: 10.1128/jvi.02228.
    PubMed         Abstract available
    
    
18. ZHOU R, Yue M, Shen Q, Liu N, et al
    Glucagon-like peptide-1 receptor agonist prevents pulmonary fibrosis following acute COVID-19 infection associated with type 2 diabetes.
    J Virol. 2026 Jul 9:e0040126. doi: 10.1128/jvi.00401.
    PubMed         Abstract available
    
    

    
    Lancet

19. DEZZA FC, Pulido LB, Borreguero IB, Perez FD, et al
    Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTE): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.
    Lancet. 2026 Jul 9:S0140-6736(26)00760-9. doi: 10.1016/S0140-6736(26)00760.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

20. 
    Efficacy and safety of rivaroxaban, colchicine, and famotidine-loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial.
    Lancet Infect Dis. 2026 Jul 8:S1473-3099(26)00242.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

21. PATRICK R, Lee K, Kuan M, Chan M, et al
    Norovirus, COVID-19, and Influenza Outbreaks Among Residents and Staff Members at the Eaton Wildfire Evacuation Shelter - Pasadena, California, January-February 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:337-342.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, July 11 '26)

 

BMC Pediatr

1. HEIBA D, Salem N, Antonios M, Shoman W, et al
   Comparative study of post- COVID-19 Kawasaki disease and multisystem inflammatory syndrome cases at Alexandria University Children's Hospital.
   BMC Pediatr. 2026;26:644.
   PubMed         Abstract available
   
   
2. LIN C, Zhu Z, Li Y, Wei J, et al
   Diagnostic value of cytokine detection in children with Mycoplasma pneumoniae pneumonia complicated by bacterial or viral co-infections.
   BMC Pediatr. 2026;26:629.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

3. DAVOODI Z, Laurie C, Tingley K, Skidmore B, et al
   Risk-of-bias assessment of vaccine effectiveness studies: a scoping review of systematic reviews.
   Epidemiol Infect. 2026;154:e95.
   PubMed         Abstract available
   
   
4. ROSCA EC, Oke J, Jefferson T, Brassey J, et al
   Serial cycle threshold to assess the infectious potential of SARS-CoV-2: A systematic review.
   Epidemiol Infect. 2026;154:e89.
   PubMed         Abstract available
   
   

   
   J Clin Microbiol

5. MCTAGGART LR, Eshaghi A, Cronin K, Patel SN, et al
   Post-pandemic surge of Mycoplasma pneumoniae in Ontario, 2024: molecular surveillance and resistance trends relative to 2018-2023.
   J Clin Microbiol. 2026;64:e0018826.
   PubMed         Abstract available
   
   

   
   J Infect

6. LI Y, Zhang T, Gao J
   Home-Based Rapid Testing and Early Antiviral Treatment as a Potential Strategy to Blunt Pediatric Influenza Peak.
   J Infect. 2026 Jul 7:106807. doi: 10.1016/j.jinf.2026.106807.
   PubMed        
   
   

   
   J Infect Dis

7. SKELLINGTON CN, Schmidt K, Schofield C, Ganesan A, et al
   The Effect of Prevaccination Analgesics on Influenza Vaccine Immunogenicity and Effectiveness.
   J Infect Dis. 2026 Jul 10:jiag334. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

8. JIA H, Lin C, Guo Y, Cai W, et al
   A neuraminidase-targeted nanobody confers broad protection against influenza B virus.
   J Virol. 2026 Jul 10:e0076226. doi: 10.1128/jvi.00762.
   PubMed         Abstract available
   
   
9. BARRON-CASTILLO U, Berube N, Swan CL, Javed MA, et al
   Receptor profiling and growth assessment of influenza A virus in porcine mammary and non-mammary tissues and derived cells.
   J Virol. 2026 Jul 6:e0061526. doi: 10.1128/jvi.00615.
   PubMed         Abstract available
   
   

   
   MMWR Morb Mortal Wkly Rep

10. PATRICK R, Lee K, Kuan M, Chan M, et al
    Norovirus, COVID-19, and Influenza Outbreaks Among Residents and Staff Members at the Eaton Wildfire Evacuation Shelter - Pasadena, California, January-February 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:337-342.
    PubMed         Abstract available
    
    

    
    Pediatrics

11. LEONARD JS, Reinhart K, Lu PJ, Santibanez TA, et al
    Influenza Vaccine Effectiveness Against Pediatric Death in the United States: 2016-2025.
    Pediatrics. 2026 Jul 6:e2026076453. doi: 10.1542/peds.2026-076453.
    PubMed         Abstract available
    
    
12. HAHN C, Sardi A, Ratner AJ
    Averting the Unthinkable: Immunization to Prevent Childhood Deaths From Influenza.
    Pediatrics. 2026 Jul 6:e2026076867. doi: 10.1542/peds.2026-076867.
    PubMed        
    
    

    
    PLoS Comput Biol

13. WANG B, Valdano E
    Redefining and estimating the early-phase reproduction ratio for epidemic outbreaks in spatially structured populations.
    PLoS Comput Biol. 2026;22:e1014425.
    PubMed         Abstract available
    
    

    
    PLoS One

14. LI W, Tan HL, Zhuang CY, Li JY, et al
    Parental knowledge, vaccine hesitancy, and practices regarding seasonal influenza vaccination for preschool-aged children in Shenzhen, China: Insights from a cross-sectional survey.
    PLoS One. 2026;21:e0353478.
    PubMed         Abstract available
    
    
15. SANOGO IN, Puryear WB, Simulynas AF, DiGiovanni R, et al
    Serological evidence of SARS-CoV-2 exposure in marine mammals in the United States between 2020 and 2025.
    PLoS One. 2026;21:e0351734.
    PubMed         Abstract available
    
    
16. HIRATA K, Chiba T, Takaku R, Meilai C, et al
    Beyond the freedom to refuse patient: A retrospective comparative study of emergency transportation during the COVID-19 pandemic in Japan.
    PLoS One. 2026;21:e0331535.
    PubMed         Abstract available
    
    
17. HAKKI S, Nevin S, Conibear E, Madon KJ, et al
    Full blood count dynamics in immunologically naive individuals with mild COVID-19: A prospective community cohort study.
    PLoS One. 2026;21:e0353142.
    PubMed         Abstract available
    
    
18. BURCHARDI JM, Brunger M, Freitag H, Brock A, et al
    Improving the care of people affected by post-COVID syndrome (LCovB):study protocol of a mixed-methods study.
    PLoS One. 2026;21:e0353270.
    PubMed         Abstract available
    
    
19. AL-AGHBARI N
    Serum albumin and blood urea as independent predictors of in-hospital mortality in hospitalized COVID-19 patients: A retrospective cohort study.
    PLoS One. 2026;21:e0353456.
    PubMed         Abstract available
    
    
20. JEWELL M, Marye A, Barbeau B, Oakeson K, et al
    Beyond traditional outbreak investigation: Using genomic data for enhanced detection of COVID-19 disease clusters in Utah.
    PLoS One. 2026;21:e0342637.
    PubMed         Abstract available
    
    
21. IIDA K, Mori H, Remez D, Krokva D, et al
    Epidemiological characteristics of amebiasis in Japan from 2001 to 2022.
    PLoS One. 2026;21:e0318901.
    PubMed         Abstract available
    
    
22. FREDERIKSEN L, Subedi S, Choong K, Anderson J, et al
    Respiratory and bloodstream coinfections and antimicrobial use in hospitalised patients with moderate to severe COVID-19: An Australian retrospective cohort study.
    PLoS One. 2026;21:e0352344.
    PubMed         Abstract available
    
    
23. FUKUDA T, Haruyama R, Tanaka Y, Natori S, et al
    Development of a COVID-19 Vaccination Anxiety Scale to measure COVID-19 vaccine anxiety in Japanese adults.
    PLoS One. 2026;21:e0330146.
    PubMed         Abstract available
    
    
24. MICHALAKI E, Van Zanten A, Najjar J, Byagathvalli G, et al
    A piezoelectric electroporator (Piezopen) for enhanced "naked" RNA vaccine delivery.
    PLoS One. 2026;21:e0353214.
    PubMed         Abstract available
    
    
25. GACH D, van Osch FHM, van den Bergh JP, Posthuma R, et al
    Long-term multidimensional health status of individuals with and without post COVID-19 condition: A cross-sectional study.
    PLoS One. 2026;21:e0352332.
    PubMed         Abstract available
    
    
26. CONGDON C, Malik F, Jina R, Kumar D, et al
    A multi-country qualitative evaluation of rapid mortality surveillance during the COVID-19 pandemic.
    PLoS One. 2026;21:e0333157.
    PubMed         Abstract available
    
    

    
    Vaccine

27. ZHANG L, Lin T, Wang M, Ma X, et al
    Retraction notice to "Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial" [Vaccine 82 (2026) 128588].
    Vaccine. 2026 Jul 6:128885. doi: 10.1016/j.vaccine.2026.128885.
    PubMed